View drug registration information details.
Items | Registration information |
ID | 1079 |
No | 1079 |
Brand Name | LOSIUM 50 |
Ingredients | LOSARTAN POTASSIUM USP 50 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU/PVC/PVDC- BLISTER |
Storage | STORE BELOW 30 C, PROTECT FROM LIGHT |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 2 X 1 X 14'S |
Dispensing Category | Prescription only |
ATC Classification | C09CA01 |
Pharmaceutical Class | ANTIHYPERTENSIVE |
Indications | TREATMENT OF ESSENTIAL HYPERTENSION IN ADULTS AND IN CHILDREN AND ADOLESCENTS 6 -18 YEARS OF AGE, TREATMENT OF CHRONIC HEART FAILURE IN ADULT PATIENT. |
Contraindications | HYPERSENSITIVITY, SECOND AND TRIRD TRIMESTER OF PREGNANCY. SEVERE HEPATIC IMPAIRMENT, CONCOMITANT USE OF LOSARTAN WITH ALISKIREN-CONTAINING PRODUCT |
Side Effects | ANAEMIA, DIZZINESS, SOMNOLENCE, HEADACHE, VERTIGO, |
Unit Price | |
EDL |
Yes |
Description | WHITE TO OFF WHITE, OVAL SHAPED, BICONVEX, FILM COATED TABLETS DEBOSSED" 50'' ON ONE SIDEAND PLAIN ON THE OTHER SIDE |
Note | |
License Owner | IC Pharma Lao Co., Ltd |
Manufacturer | CADILA PHARMACEUTICALS LIMITED |
Country | INDIA |
Import Registration No | MFG/CADILA/16783/B |
Import Registration Date | 2018-02-14 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-10 |
FDD Registration No | 03 I 5403/23 |
FDD Registration Date | 2023-03-17 |
Expiry Date | 2026-03-16 |
Back to drug list
|